Richard L. Doty, Ph.D.
Director, Smell & Taste Center,
Professor, Dept of Otorhinolaryngology
School of Medicine
5 Ravdin Building/4283
(215) 662-6580 FAX: (215) 349-5266
email: doty@mail.med.upenn.edu
Click here for selected publications since Dr. Doty's arrival at Penn
RESEARCH INTERESTS
Aging; olfaction; taste; behavioral pharmacology; neurodegenerative diseases
& schizophrenia; chemosensory psychophysics; psychopharmacology; multiple
sclerosis; functional magnetic resonance imaging.
RESEARCH TECHNIQUES
Psychophysical procedures; olfactometry -- both human and animal; ablation;
endocrine manipulation; lesioning; neuropharmacology; anterior rhinomanometry;
acoustic rhinometry; event-related electrophysiological potentials; fMRI
RESEARCH SUMMARY
My research is focused on better understanding the chemical senses (olfaction
and taste) from both basic and clinical perspectives. Clinically, I am
very much interested in the changes which occur in olfactory function
in a number of disease states. We have demonstrated, for example, that
individuals with Parkinson's disease and with Alzheimer's disease often
have major loss of smell function.
Another research area in which I am actively engaged is that of neuropharmacological
manipulation of olfactory perception. We have shown, for example, that
low doses of d-amphetamine enhance the rat's ability to detect odorants,
whereas moderate doses depress such ability. This research uses sophisticated
computer-controlled olfactometers and operant conditioning signal detection
tasks to measure the sensitivity of the animals. We have found that 6-OHDA
elimination of olfactory bulb norepinephrine has no effect on odor detection
performance, however, suggesting that the d-amphetamine phenomenon may
not be mediated through locus coeruleus projections to the olfactory bulb.
We are currently evaluating the influences of D-1 and D-2 receptor agonists
and antagonists to better understand the mechanisms producing this and
related phenomena.
A major research focus has been to develop clinically useful smell and
taste tests. The University of Pennsylvania Smell Identification Test
- a product of this program - is now the international standard for human
olfactory measurement and is used in thousands of clinics and laboratories
throughout the world. Associated with this program is the exploration
of the influences of procedural variables upon quantitative measures of
olfactory function.
Other research areas of interest include: (a) correlation of plaque
numbers in circumscribed brain regions in multiple sclerosis with quantitative
measures of audition, balance, taste, smell & touch; (b) influences of
estrogen on preventing or mitigating age-related sensory changes; (c)
influences of neurotoxic agents on smell and taste function; (d) age-related
influences on sensory function; (e) disease-related histological changes
in the olfactory pathways.
KEY WORDS:
Olfaction; taste; neurological disorders; psychopharmacology
|